|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-11-20
|
|
pubmed:abstractText |
Tumour necrosis factor-alpha upregulates the expression of a cutaneous T cell-attracting chemokine (CTACK/CCL27), that promotes migration of cutaneous lymphocyte-associated antigen-positive lymphocytes into the skin. The role of CTACK/CCL27 in pathogenesis of psoriasis has recently been documented but no data are available at the present time on its modification in psoriatic cutaneous tissue after administration of etanercept.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
pubmed-author:BernardiniM LML,
pubmed-author:CampanatiAA,
pubmed-author:FabrisGG,
pubmed-author:GanzettiGG,
pubmed-author:GiuliodoriKK,
pubmed-author:GoteriGG,
pubmed-author:MannelloBB,
pubmed-author:MorichettiDD,
pubmed-author:OffidaniAA,
pubmed-author:SimonettiOO,
pubmed-author:StramazzottiDD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
157
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1155-60
|
|
pubmed:meshHeading |
pubmed-meshheading:17916208-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:17916208-Chemokine CCL27,
pubmed-meshheading:17916208-Female,
pubmed-meshheading:17916208-Humans,
pubmed-meshheading:17916208-Immunoglobulin G,
pubmed-meshheading:17916208-Immunohistochemistry,
pubmed-meshheading:17916208-Male,
pubmed-meshheading:17916208-Psoriasis,
pubmed-meshheading:17916208-Receptors, Chemokine,
pubmed-meshheading:17916208-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:17916208-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.
|
|
pubmed:affiliation |
Dermatological Clinic, Department of Medical Sciences, Ancona Hospital, Polytechnic University of Marche Region, Via Conca 71, Ancona, Italy. a.campanati@ao-umbertoprimo.marche.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
